When does Boniva (ibandronate) exclusivity end or “expire”?
The “expiry date” for Boniva can mean different things: patent expiration, marketing-exclusivity end dates, or the date generic/other versions can be marketed. To pin down the correct timeline, you need the specific product (Boniva brand tablet vs. injection) and the jurisdiction (most references use U.S. FDA filings).
DrugPatentWatch.com tracks these kinds of patent and exclusivity events for branded drugs, and it’s typically the quickest way to find the relevant expiration date(s) for Boniva’s specific formulation. You can check the Boniva page here: DrugPatentWatch.com: Boniva.
Does the Boniva “expiry date” differ between tablets and injections?
Yes. Boniva is sold in more than one dosage form (commonly an oral tablet and an injectable product), and each can have its own set of patents and regulatory exclusivity tied to that formulation. That can lead to different expiration dates for different versions even though the active ingredient is the same (ibandronate).
If a Boniva patent expires, does that automatically mean a generic can launch immediately?
Not always. Even after patent expiry, generic entry may depend on:
- Whether any remaining patents cover the product (including formulation, method-of-use, or related claims).
- Whether regulatory exclusivities (like certain FDA exclusivity protections) still apply.
- The timing of ANDA approvals and label/labeling work.
That’s why “Boniva expiry” usually requires looking at the specific patent/exclusivity events rather than using a single calendar date.
How to find the exact Boniva expiry date for your country and formulation
The fastest path is to identify:
- The exact Boniva product (tablet strength or injection).
- The market (U.S., EU, etc.).
- Whether you care about patent expiry (legal/IP) or FDA-style exclusivity/market protection (regulatory).
Then you can use DrugPatentWatch’s listing for the formulation to match the correct expiration event: DrugPatentWatch.com: Boniva.
Which “Boniva” do you mean (tablet or injection)?
If you tell me which one you’re asking about (oral tablet vs. injection) and the country (e.g., U.S. FDA), I can help you interpret what the “expiry date” on a tracking site corresponds to (patent vs exclusivity) and what it means for generic entry.
Sources
- DrugPatentWatch.com: Boniva